TherapeuticsMD

TherapeuticsMD is an innovative pharmaceutical company exclusively focused on advancing women's health and raising awareness of their healthcare issues. Founded in 2008 and based in the United States, the company is committed to creating products that address the unique changes and challenges women experience throughout their lives. With a strong focus on meeting customer needs, TherapeuticsMD combines entrepreneurial spirit and clinical expertise to develop innovative solutions that surpass existing options. The company's pipeline includes a variety of therapies and prescription prenatal vitamins under the vitaMedMD® and BocaGreenMD® brands.

TherapeuticsMD's last investment amounted to $1.15M in Post-IPO Equity, received on 10 July 2023. While the specific investors for this round are not disclosed, their continued investment in the company reflects confidence in its mission and potential for growth within the Biotechnology, Health Care, and Pharmaceutical industries. TherapeuticsMD's dedication to women's health and its ongoing innovation in this space position it as a compelling prospect for investors seeking opportunities in the healthcare sector.

For Her. For Life. This slogan encapsulates TherapeuticsMD's unwavering commitment to advancing women's health and underscores its potential to make a meaningful impact in the pharmaceutical industry.

See their community guidelines here.